In this study, publicly available profiles were collected and integrated, and a comprehensive analysis was performed to investigate the role of SWI/SNF complex gene mutations in the prognosis of patients with NSCLC treated with anti-PD-1/PD-L1 ICIs. Here, SMARCA1 is linked to non-small cell lung carcinoma.